JP2005529084A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005529084A5 JP2005529084A5 JP2003576414A JP2003576414A JP2005529084A5 JP 2005529084 A5 JP2005529084 A5 JP 2005529084A5 JP 2003576414 A JP2003576414 A JP 2003576414A JP 2003576414 A JP2003576414 A JP 2003576414A JP 2005529084 A5 JP2005529084 A5 JP 2005529084A5
- Authority
- JP
- Japan
- Prior art keywords
- parecoxib sodium
- drug substance
- anhydrous
- parecoxib
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229960003925 parecoxib sodium Drugs 0.000 claims 25
- ICJGKYTXBRDUMV-UHFFFAOYSA-N trichloro(6-trichlorosilylhexyl)silane Chemical compound Cl[Si](Cl)(Cl)CCCCCC[Si](Cl)(Cl)Cl ICJGKYTXBRDUMV-UHFFFAOYSA-N 0.000 claims 25
- 239000008186 active pharmaceutical agent Substances 0.000 claims 11
- 229940088679 drug related substance Drugs 0.000 claims 11
- 238000000634 powder X-ray diffraction Methods 0.000 claims 5
- 238000000034 method Methods 0.000 claims 4
- 238000001157 Fourier transform infrared spectrum Methods 0.000 claims 3
- 238000000113 differential scanning calorimetry Methods 0.000 claims 3
- 238000001757 thermogravimetry curve Methods 0.000 claims 3
- 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 claims 2
- 108050003267 Prostaglandin G/H synthase 2 Proteins 0.000 claims 2
- 239000013078 crystal Substances 0.000 claims 2
- 230000001404 mediated effect Effects 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 239000012736 aqueous medium Substances 0.000 claims 1
- 238000002425 crystallisation Methods 0.000 claims 1
- 230000008025 crystallization Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36456702P | 2002-03-15 | 2002-03-15 | |
| US41798702P | 2002-10-11 | 2002-10-11 | |
| PCT/US2003/007484 WO2003078408A1 (en) | 2002-03-15 | 2003-03-12 | Crystalline parecoxib sodium |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005529084A JP2005529084A (ja) | 2005-09-29 |
| JP2005529084A5 true JP2005529084A5 (enExample) | 2006-04-27 |
Family
ID=28045416
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003576414A Pending JP2005529084A (ja) | 2002-03-15 | 2003-03-12 | 結晶性パレコキシブナトリウム |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20030232871A1 (enExample) |
| EP (1) | EP1485362A1 (enExample) |
| JP (1) | JP2005529084A (enExample) |
| KR (1) | KR100763045B1 (enExample) |
| CN (1) | CN1642926A (enExample) |
| AR (1) | AR038985A1 (enExample) |
| AU (1) | AU2003220180A1 (enExample) |
| BR (1) | BR0308431A (enExample) |
| CA (1) | CA2478500A1 (enExample) |
| CO (1) | CO5631437A2 (enExample) |
| IL (1) | IL163780A0 (enExample) |
| MX (1) | MXPA04008932A (enExample) |
| MY (1) | MY148518A (enExample) |
| NZ (1) | NZ535951A (enExample) |
| PL (1) | PL372880A1 (enExample) |
| RU (1) | RU2300529C2 (enExample) |
| TW (1) | TW200400949A (enExample) |
| WO (1) | WO2003078408A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050143431A1 (en) * | 2003-04-04 | 2005-06-30 | Hetero Drugs Limited | Novel crystalline forms of parecoxib sodium |
| CA2930900C (en) * | 2003-10-02 | 2018-10-16 | Jazz Pharmaceuticals International Limited | Combinations of ziconotide and opioids for reducing pain |
| CA2551523A1 (en) * | 2003-12-24 | 2005-07-21 | Pharmacia Corporation | Metal salts of parecoxib as prodrugs of the cox-2 inhibitor valdecoxib for the treatment of inflammation, pain and/or fever |
| ITMI20040019A1 (it) * | 2004-01-12 | 2004-04-12 | Univ Bari | Derivati isossazolici e loro impiego come inibitori della ciclossigenasi |
| US7796785B2 (en) * | 2005-03-03 | 2010-09-14 | Fujifilm Corporation | Image extracting apparatus, image extracting method, and image extracting program |
| US20080108664A1 (en) * | 2005-12-23 | 2008-05-08 | Liu Belle B | Solid-state form of AMG 706 and pharmaceutical compositions thereof |
| US7989450B2 (en) | 2008-01-11 | 2011-08-02 | Universita' Degli Studi Di Bari | Functionalized diarylisoxazoles inhibitors of ciclooxygenase |
| GB0919757D0 (en) * | 2009-11-12 | 2009-12-30 | Johnson Matthey Plc | Polymorphs of bromfenac sodium and methods for preparing bromfenac sodium polymorphs |
| US8299295B2 (en) | 2009-10-15 | 2012-10-30 | Johnson Matthey Public Limited Company | Polymorphs of bromfenac sodium and methods for preparing bromfenac sodium polymorphs |
| CN105726496B (zh) * | 2014-12-12 | 2019-05-28 | 湖南科伦药物研究有限公司 | 一种帕瑞昔布钠冻干粉剂、其制备方法及其粉剂产品 |
| CN105125506A (zh) * | 2015-08-18 | 2015-12-09 | 上海秀新臣邦医药科技有限公司 | 一种注射用帕瑞昔布钠及其制备方法 |
| CN106580893A (zh) * | 2016-12-26 | 2017-04-26 | 上药东英（江苏）药业有限公司 | 一种帕瑞昔布钠冻干粉针制剂 |
| CN106692079A (zh) * | 2016-12-26 | 2017-05-24 | 上药东英（江苏）药业有限公司 | 一种帕瑞昔布钠长效冻干粉针制剂 |
| CN117003769B (zh) * | 2023-07-11 | 2024-11-22 | 中国科学院宁波材料技术与工程研究所 | 氯诺昔康复合物、氯诺昔康-小檗碱共晶及其制备方法和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK285353B6 (sk) * | 1996-04-12 | 2006-11-03 | G. D. Searle & Co. | Substituované benzénsulfónamidy ako proliečivá COX-2 inhibítorov, farmaceutická kompozícia a spôsobich prípravy a použitia |
| SK284788B6 (sk) * | 1996-10-15 | 2005-11-03 | G. D. Searle & Co. | Použitie inhibítorov cyklooxygenázy-2 pri liečení a prevencii neoplázie |
| MY137736A (en) * | 2001-04-03 | 2009-03-31 | Pharmacia Corp | Reconstitutable parenteral composition |
| CN1308315C (zh) * | 2001-10-02 | 2007-04-04 | 法玛西雅公司 | 制备苯磺酰基化合物的方法 |
-
2003
- 2003-03-12 MX MXPA04008932A patent/MXPA04008932A/es unknown
- 2003-03-12 NZ NZ535951A patent/NZ535951A/en unknown
- 2003-03-12 KR KR1020047014454A patent/KR100763045B1/ko not_active Expired - Fee Related
- 2003-03-12 CN CNA038060884A patent/CN1642926A/zh active Pending
- 2003-03-12 JP JP2003576414A patent/JP2005529084A/ja active Pending
- 2003-03-12 EP EP03716476A patent/EP1485362A1/en not_active Withdrawn
- 2003-03-12 RU RU2004127585/04A patent/RU2300529C2/ru not_active IP Right Cessation
- 2003-03-12 AU AU2003220180A patent/AU2003220180A1/en not_active Abandoned
- 2003-03-12 US US10/387,173 patent/US20030232871A1/en not_active Abandoned
- 2003-03-12 BR BR0308431-0A patent/BR0308431A/pt not_active IP Right Cessation
- 2003-03-12 IL IL16378003A patent/IL163780A0/xx unknown
- 2003-03-12 WO PCT/US2003/007484 patent/WO2003078408A1/en not_active Ceased
- 2003-03-12 CA CA002478500A patent/CA2478500A1/en not_active Abandoned
- 2003-03-12 PL PL03372880A patent/PL372880A1/xx not_active Application Discontinuation
- 2003-03-14 AR ARP030100915A patent/AR038985A1/es unknown
- 2003-03-14 MY MYPI20030900A patent/MY148518A/en unknown
- 2003-03-14 TW TW092105693A patent/TW200400949A/zh unknown
-
2004
- 2004-09-10 CO CO04090186A patent/CO5631437A2/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005529084A5 (enExample) | ||
| JP2009534373A5 (enExample) | ||
| JP2021119136A5 (enExample) | ||
| CN101573368B (zh) | 结晶型1-(β-D-吡喃葡糖基)-4-甲基-3-[5-(4-氟苯基)-2-噻吩基甲基]苯半水合物 | |
| ES2351958T3 (es) | 5-cloro-3-(4-metanosulfonilfenil)-6'-metil-[2,3'] bipiridinil en forma cristalina pura y procedimiento de síntesis. | |
| HRP20120007T1 (hr) | Polimorfni oblik 4-[3-(4-ciklopropankarbonil-piperazin-1-karbonil)-4-fluoro-benzil]-2h-ftalazin-1-ona | |
| ES2460919T3 (es) | Formas polimórficas de p-hidroxibenzoato de (2S)-(4E)-N-metil-5-[3-(5-isopropoxipiridin)il]-4-penten-2-amonio para el tratamiento de trastornos del sistema nervioso central | |
| HRP20231533T1 (hr) | Kristalni oblici od (s)-1-(4-fluorofenil)-1-(2-(4-(6-(1-metil-1h-pirazol-4-il)pirolo[2,1-f][1,2,4 ]triazin-4-il)piperazinil)-pirimidin-5-il)etan-1-amina i postupci priprave | |
| JP2005501074A (ja) | パロキセチン・グリチルリチン酸塩 | |
| JP2008513358A5 (enExample) | ||
| WO2011143872A1 (zh) | 一种(s)-4-羟基-2-氧代-1-吡咯烷乙酰胺晶型及其制备方法和用途 | |
| JP2016503010A5 (enExample) | ||
| RU2007109598A (ru) | Кристаллическая форма бифенильного соединения | |
| JP2010514725A5 (enExample) | ||
| JP2010132669A (ja) | ストロンチウムラネレートのアルファー（α）−結晶形、その製造方法、及びそれを含む医薬組成物 | |
| TW202200594A (zh) | 一種glp-1受體激動劑的晶型a及其製備方法 | |
| JP2020536893A5 (enExample) | ||
| RU2004127585A (ru) | Кристаллическая натриевая соль парекоксиба | |
| RU2009124113A (ru) | Кристаллические формы glyt1 | |
| WO2005085199A1 (en) | Novel polymorphs of etoricoxib | |
| JP2010540470A5 (enExample) | ||
| CN103755723B (zh) | 一种利福平i晶型的制备方法 | |
| JP2004517088A5 (enExample) | ||
| TW200400043A (en) | A process for the preparation of piroxicam: β -cyclodextrin inclusion compounds | |
| JP2010540440A5 (enExample) |